中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2015年
10期
1543-1545,1546
,共4页
微波分离%戊酸雌二醇%宫颈粘连%治疗结果
微波分離%戊痠雌二醇%宮頸粘連%治療結果
미파분리%무산자이순%궁경점련%치료결과
Microwave Separation%Estradiol valerate%Cervical adhesions%Treatment Outcome
目的：观察微波分离联合戊酸雌二醇口服治疗宫颈原位癌宫颈锥切术后宫颈粘连的临床效果。方法选择给予微波分离治疗的宫颈粘连患者82例（因宫颈原位癌行宫颈锥切术后发生宫颈粘连）为对照组；另选择宫颈粘连患者86例（因宫颈原位癌行宫颈锥切术后发生宫颈粘连）为观察组，给予微波分离联合戊酸雌二醇口服治疗，比较两组疗效及不良反应情况。结果观察组和对照组治疗1个月后，子宫内膜厚度分别为（8．56±2．54）mm 和（7．96±2．64）mm，均显著优于治疗前的（4．38±1．90）mm 和（4．36±2．10）mm。且观察组的子宫内膜厚度优于对照组（均 P ＜0．05）；治疗3个月后，对照组宫腔粘连患者治愈率为63．41％，总有效率为82．93％；观察组宫腔粘连患者治愈率为70．93％，总有效率为91．86％，两组治愈率和总有效率差异均有统计学意义（χ2＝5．48，P ＜0．05）；治疗后1个月，观察组患者月经改善率（95.35％）优于对照组（89．02％），差异有统计学意义（χ2＝6．38，P ＜0．05）。对照组和观察组的不良反应发生率分别为9．76％和3．49％（χ2＝7．25，P ＜0．05）。结论微波分离联合戊酸雌二醇口服治疗宫颈原位癌宫颈锥切术后宫颈粘连临床有效率高，不良反应小，值得临床推广应用。
目的：觀察微波分離聯閤戊痠雌二醇口服治療宮頸原位癌宮頸錐切術後宮頸粘連的臨床效果。方法選擇給予微波分離治療的宮頸粘連患者82例（因宮頸原位癌行宮頸錐切術後髮生宮頸粘連）為對照組；另選擇宮頸粘連患者86例（因宮頸原位癌行宮頸錐切術後髮生宮頸粘連）為觀察組，給予微波分離聯閤戊痠雌二醇口服治療，比較兩組療效及不良反應情況。結果觀察組和對照組治療1箇月後，子宮內膜厚度分彆為（8．56±2．54）mm 和（7．96±2．64）mm，均顯著優于治療前的（4．38±1．90）mm 和（4．36±2．10）mm。且觀察組的子宮內膜厚度優于對照組（均 P ＜0．05）；治療3箇月後，對照組宮腔粘連患者治愈率為63．41％，總有效率為82．93％；觀察組宮腔粘連患者治愈率為70．93％，總有效率為91．86％，兩組治愈率和總有效率差異均有統計學意義（χ2＝5．48，P ＜0．05）；治療後1箇月，觀察組患者月經改善率（95.35％）優于對照組（89．02％），差異有統計學意義（χ2＝6．38，P ＜0．05）。對照組和觀察組的不良反應髮生率分彆為9．76％和3．49％（χ2＝7．25，P ＜0．05）。結論微波分離聯閤戊痠雌二醇口服治療宮頸原位癌宮頸錐切術後宮頸粘連臨床有效率高，不良反應小，值得臨床推廣應用。
목적：관찰미파분리연합무산자이순구복치료궁경원위암궁경추절술후궁경점련적림상효과。방법선택급여미파분리치료적궁경점련환자82례（인궁경원위암행궁경추절술후발생궁경점련）위대조조；령선택궁경점련환자86례（인궁경원위암행궁경추절술후발생궁경점련）위관찰조，급여미파분리연합무산자이순구복치료，비교량조료효급불량반응정황。결과관찰조화대조조치료1개월후，자궁내막후도분별위（8．56±2．54）mm 화（7．96±2．64）mm，균현저우우치료전적（4．38±1．90）mm 화（4．36±2．10）mm。차관찰조적자궁내막후도우우대조조（균 P ＜0．05）；치료3개월후，대조조궁강점련환자치유솔위63．41％，총유효솔위82．93％；관찰조궁강점련환자치유솔위70．93％，총유효솔위91．86％，량조치유솔화총유효솔차이균유통계학의의（χ2＝5．48，P ＜0．05）；치료후1개월，관찰조환자월경개선솔（95.35％）우우대조조（89．02％），차이유통계학의의（χ2＝6．38，P ＜0．05）。대조조화관찰조적불량반응발생솔분별위9．76％화3．49％（χ2＝7．25，P ＜0．05）。결론미파분리연합무산자이순구복치료궁경원위암궁경추절술후궁경점련림상유효솔고，불량반응소，치득림상추엄응용。
Objective To investigate the microwave separation combined oral estradiol valerate treatment of cervical carcinoma in situ of the clinical effects of postoperative adhesions cervical conization.Methods Microwave separation treatment was given to 82 patients with cervical adhesions (for cervical carcinoma in situ in line of the cer-vical cone postoperative cervical adhesion)for the control group;86 patients with select cervical adhesion (for cervi-cal carcinoma in situ in line of the cervical cone postoperative cervical adhesion)for the observation group and gyne-cology (because of cervical carcinoma in situ cervical conization of cervical adhesions),estradiol valerate give micro-wave separation combined oral treatment,compare two groups and adverse reactions.Results After treatment a month,endometrial thickness,respectively (8.56 ±2.54)mm and (7.96 ±2.64)mm,and were significantly better than before treatment (4.38 ±1.90)mm and (4.36 ±2.10)mm.Endometrial thickness of the observation group was better than that in the control group(P <0.05 );after three months of treatment,caused by intrauterine adhesions patients in the control group was 63.41%,total effective rate was 82.93%;Caused by intrauterine adhesions in the observation group cure rate was 70.93%,total effective rate was 91.86%,the total cure rate and total effective rate, the difference between the two groups had statistical significance (χ2 =5.48,P <0.05);After treatment a month,the observation group of patients with menstrual period 95.35% better than the control group 89.02%,difference was sta-tistically significant (χ2 =6.38,P <0.05).The incidences of adverse reactions in the control group and observation group were 9.76% and 3.49% respectively (χ2 =7.25,P <0.05).Conclusion Microwave separation combined oral estradiol valerate treatment of cervical carcinoma in situ cervical conization cervical adhesions had clinically effec-tive rate,side effects,which is worthy of clinical application.
